NASDAQ:CATB - Catabasis Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$7.30 -0.16 (-2.14 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$7.30
Today's Range$7.17 - $7.63
52-Week Range$3.60 - $20.40
Volume280,644 shs
Average Volume271,625 shs
Market Capitalization$83.88 million
P/E Ratio-1.43
Dividend YieldN/A
Beta1.64

SEC Filings

Catabasis Pharmaceuticals (NASDAQ:CATB) SEC Filings

DateFilerForm TypeView
03/14/2019
6:31 AM
Catabasis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/19/2019
3:48 PM
ARMISTICE CAPITAL, LLC (Filed by)
Catabasis Pharmaceuticals (Subject)
Form SC 13G
View Filing
02/15/2019
7:42 AM
Catabasis Pharmaceuticals (Issuer)
Cunnane Deirdre A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2019
7:41 AM
Catabasis Pharmaceuticals (Issuer)
Nichols Andrew John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2019
7:41 AM
Catabasis Pharmaceuticals (Issuer)
Donovan Joanne M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2019
7:40 AM
Catabasis Pharmaceuticals (Issuer)
Milne Jill C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2019
7:37 AM
Catabasis Pharmaceuticals (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2019
7:36 AM
Beck Joanne T. (Reporting)
Catabasis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/15/2019
7:35 AM
Beck Joanne T. (Reporting)
Catabasis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/14/2019
3:02 PM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/13/2019
4:21 PM
Catabasis Pharmaceuticals (Subject)
Corriente Advisors, LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
3:25 PM
Catabasis Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
View Filing
02/13/2019
3:06 PM
Catabasis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/13/2019
2:17 PM
Catabasis Pharmaceuticals (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G/A
View Filing
02/06/2019
3:24 PM
Catabasis Pharmaceuticals (Filer)
Form 424B5
View Filing
02/06/2019
3:21 PM
Catabasis Pharmaceuticals (Filer)
Form 424B5
View Filing
02/06/2019
3:13 PM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/05/2019
4:27 PM
Catabasis Pharmaceuticals (Filer)
Form 424B5
View Filing
02/05/2019
3:01 PM
Catabasis Pharmaceuticals (Filer)
Form 424B5
View Filing
01/17/2019
10:51 AM
Catabasis Pharmaceuticals (Subject)
Empery Asset Management, LP (Filed by)
Form SC 13G/A
View Filing
01/09/2019
3:13 PM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2019
3:04 PM
Catabasis Pharmaceuticals (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
Form 4/A
View Filing
01/04/2019
8:24 AM
Catabasis Pharmaceuticals (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
8:23 AM
Catabasis Pharmaceuticals (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/31/2018
4:16 PM
Catabasis Pharmaceuticals (Filer)
Form 424B3
View Filing
12/31/2018
4:13 PM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/14/2018
6:23 AM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
7:52 AM
Catabasis Pharmaceuticals (Filer)
Form 424B3
View Filing
11/13/2018
7:48 AM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/13/2018
7:46 AM
Catabasis Pharmaceuticals (Filer)
Form 424B5
View Filing
11/13/2018
6:31 AM
Catabasis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/23/2018
3:12 PM
Catabasis Pharmaceuticals (Filer)
Form DEF 14A
View Filing
10/16/2018
3:01 PM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
3:03 PM
Catabasis Pharmaceuticals (Filer)
Form PRE 14A
View Filing
09/11/2018
3:15 PM
Catabasis Pharmaceuticals (Issuer)
Cunnane Deirdre A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/11/2018
3:14 PM
Catabasis Pharmaceuticals (Issuer)
Nichols Andrew John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/11/2018
3:13 PM
Catabasis Pharmaceuticals (Issuer)
Donovan Joanne M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/11/2018
3:12 PM
Catabasis Pharmaceuticals (Issuer)
Milne Jill C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
7:02 AM
Catabasis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
07/10/2018
10:30 AM
Catabasis Pharmaceuticals (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G
View Filing
07/02/2018
4:01 PM
ARMISTICE CAPITAL, LLC (Filed by)
Catabasis Pharmaceuticals (Subject)
Form SC 13G
View Filing
06/28/2018
3:58 PM
Catabasis Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
View Filing
06/25/2018
1:14 PM
Catabasis Pharmaceuticals (Subject)
Empery Asset Management, LP (Filed by)
Form SC 13G
View Filing
06/20/2018
4:25 PM
Catabasis Pharmaceuticals (Filer)
Form 424B4
View Filing
06/20/2018
8:13 AM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/20/2018
5:04 AM
Catabasis Pharmaceuticals (Filer)
Form S-1MEF
View Filing
06/19/2018
11:15 PM
Catabasis Pharmaceuticals (Filer)
Form EFFECT
View Filing
06/18/2018
8:22 AM
Catabasis Pharmaceuticals (Filer)
Form S-1/A
View Filing
06/15/2018
8:25 AM
Catabasis Pharmaceuticals (Filer)
Form S-1/A
View Filing
06/12/2018
4:17 PM
Catabasis Pharmaceuticals (Filer)
Form S-1/A
View Filing
06/07/2018
5:19 PM
Catabasis Pharmaceuticals (Issuer)
Ross Michael Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
5:07 PM
Catabasis Pharmaceuticals (Issuer)
KISHBAUCH MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
5:06 PM
ADELMAN BURT A (Reporting)
Catabasis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
5:05 PM
BATE KENNETH (Reporting)
Catabasis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
5:04 PM
Catabasis Pharmaceuticals (Issuer)
George Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
3:03 PM
Catabasis Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
View Filing
05/10/2018
7:01 AM
Catabasis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/26/2018
3:10 PM
Catabasis Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/26/2018
3:09 PM
Catabasis Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/17/2018
3:02 PM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/04/2018
3:42 PM
Catabasis Pharmaceuticals (Subject)
Clarus Lifesciences II, L.P. (Filed by)
Form SC 13D/A
View Filing
03/16/2018
3:03 PM
Catabasis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
03/15/2018
3:02 PM
Catabasis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/23/2018
7:27 AM
Catabasis Pharmaceuticals (Subject)
Corriente Advisors, LLC (Filed by)
Form SC 13G
View Filing
02/14/2018
2:33 PM
Advanced Technology Ventures VIII LP (Filed by)
Catabasis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/14/2018
8:57 AM
Camber Capital Management LLC (Filed by)
Catabasis Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/13/2018
7:15 AM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/09/2018
3:02 PM
Catabasis Pharmaceuticals (Issuer)
Cunnane Deirdre A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/09/2018
3:02 PM
Catabasis Pharmaceuticals (Issuer)
Nichols Andrew John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/09/2018
3:02 PM
Catabasis Pharmaceuticals (Issuer)
Donovan Joanne M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/09/2018
3:01 PM
Catabasis Pharmaceuticals (Issuer)
Milne Jill C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/09/2018
3:01 PM
Catabasis Pharmaceuticals (Issuer)
Hibben Edward K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/09/2018
11:07 AM
Catabasis Pharmaceuticals (Subject)
Clarus Lifesciences II, L.P. (Filed by)
Form SC 13D/A
View Filing
12/11/2017
6:03 AM
Catabasis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What are gap-up stocks?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel